Explore how checkpoint kinase 1 inhibitors are revolutionizing treatment for ovarian clear cell carcinoma, a chemoresistant ovarian cancer subtype.
Discover how tolfenamic acid, a common migraine drug, shows promise in fighting ovarian cancer by targeting key proteins and transcription factors.
Discover how Granulosa Cell Tumors evade programmed cell death through molecular mechanisms involving Fas, FLIP, and Bcl-2 proteins.
Discover how the complex molecular relationship between p53, ANXA4, and NF-κB p50 drives ovarian clear cell carcinoma progression and resistance to chemotherapy.
Discover how modified citrus pectin (PectaSol-C) enhances ovarian cancer therapy by targeting Galectin-3 and synergizing with paclitaxel.